AML-1020: CR/CRi and MRD Outcomes With Intensive vs Low-Intensity Chemotherapy in AML: A Single-Center Retrospective Analysis
Year: 2026
Type: conference-abstract
Institution: Baylor College of Medicine
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: acute myeloid leukemia, venetoclax, low-intensity chemotherapy, intensive chemotherapy, complete remission, measurable residual disease negativity, depth of response, induction chemotherapy, ELN risk stratification, multiparameter flow cytometry, newly diagnosed AML, elderly patients, prognostic factors
Open Access status: closed
OpenAlex ID: W7204703142
